glp-1 obesity drug market size 2025 The United States Agonists Weight Loss Drugs & Outlook, 2030 GLP-1 Agonists Market Report 2025-2033,

The resulting IGFBP-5 downregulation enhanced anchorage-independent growth of melanoma cell lines, the proposed mechanism being enhanced IGF1R signaling, although this was not demonstrated [73]

In controlled research environments, it is used as a model compound in studies involving redox processes, molecular interactions, and experimental biological frameworks

Nevertheless, other randomized clinical trials failed to demonstrate any beneficial effect of selenium supplementation in GD (81, 82) or in HT [79, 80]

A pathophysiological mechanism underlying pregnancy-associated thyroid disorders as HT and PPT involves a complex interplay of genetic predisposition, epigenetic modifications, immune dysregulation, and chronic inflammation, all of which contribute to oxidative stress and progressive thyroid dysfunction [19]